Learn / AUTL
NASDAQ: AUTL
Autolus Therapeutics plc (AUTL) stock, explained like you're 5
Autolus Therapeutics plc trades on the Nasdaq under the ticker AUTL. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 482 million dollars.
- Ticker
- AUTL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 482 million dollars
Is Autolus Therapeutics plc a small, medium or large cap company?
No. Autolus Therapeutics plc is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 482 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Autolus Therapeutics plc makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AUTL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Autolus Therapeutics (AUTL) Stock Sees Split Analyst Revisions After Early Aucatyzl Launch Signals (Yahoo Finance)
- Autolus Therapeutics (NasdaqGS:AUTL) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Autolus Therapeutics plc SEC Filing (Sep 23, 2026) (Stock Titan)
- Autolus Therapeutics: Navigating A Bumpy 2026 (NASDAQ:AUTL) (Seeking Alpha)
- AUTOLUS THERAPEUTICS ($AUTL) Releases Q2 2026 Earnings (Quiver Quantitative)
Follow AUTL in your daily brief
Each trading day at 5 PM ET we post what happened to Autolus Therapeutics plc and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AUTL
Questions about Autolus Therapeutics plc stock
What does Autolus Therapeutics plc do?
Autolus Therapeutics plc trades on the Nasdaq under the ticker AUTL. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 482 million dollars.
What is the ticker symbol for Autolus Therapeutics plc?
Autolus Therapeutics plc trades under the ticker AUTL on the Nasdaq.
What is Autolus Therapeutics plc's market cap?
Autolus Therapeutics plc is a small cap stock with a market cap of about 482 million dollars.
How does Autolus Therapeutics plc make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AUTL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AUTL stock every day?
Add AUTL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.